PRSS1 Gene Pancreatitis Genetic Test
Cost: 4400.0 AED
Test Components:
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hepatology Nephrology Endocrinology Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for PRSS1 Gene Pancreatitis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PRSS1 Gene Pancreatitis NGS Genetic DNA Test gene PRSS1.
Test Details:
The PRSS1 gene is associated with hereditary pancreatitis, a condition characterized by recurrent episodes of inflammation in the pancreas. A genetic test for PRSS1 gene mutations can help identify individuals who are at an increased risk of developing pancreatitis.
NGS (Next-Generation Sequencing) is a technology used for genetic testing that allows for the simultaneous analysis of multiple genes. In the case of PRSS1 gene testing, NGS can detect mutations or variations in the gene that may be responsible for pancreatitis.
The PRSS1 gene encodes for an enzyme called trypsinogen, which is involved in the digestion of proteins in the pancreas. Mutations in the PRSS1 gene can lead to the production of an abnormal form of trypsinogen, which can be prematurely activated and cause inflammation in the pancreas.
Genetic testing for PRSS1 gene mutations can be beneficial for individuals with a family history of pancreatitis or those who have had multiple episodes of unexplained pancreatitis. Identifying a mutation in the PRSS1 gene can help with early diagnosis, appropriate management, and genetic counseling for affected individuals and their family members.
It is important to note that a positive genetic test for PRSS1 gene mutations does not necessarily mean an individual will develop pancreatitis. Other genetic and environmental factors also play a role in the development of the condition. Therefore, the results of genetic testing should be interpreted in the context of a person’s clinical history and other risk factors.
Test Name | PRSS1 Gene Pancreatitis Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PRSS1 Gene Pancreatitis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PRSS1 Gene Pancreatitis NGS Genetic DNA Test gene PRSS1 |
Test Details |
The PRSS1 gene is associated with hereditary pancreatitis, a condition characterized by recurrent episodes of inflammation in the pancreas. A genetic test for PRSS1 gene mutations can help identify individuals who are at an increased risk of developing pancreatitis. NGS (Next-Generation Sequencing) is a technology used for genetic testing that allows for the simultaneous analysis of multiple genes. In the case of PRSS1 gene testing, NGS can detect mutations or variations in the gene that may be responsible for pancreatitis. The PRSS1 gene encodes for an enzyme called trypsinogen, which is involved in the digestion of proteins in the pancreas. Mutations in the PRSS1 gene can lead to the production of an abnormal form of trypsinogen, which can be prematurely activated and cause inflammation in the pancreas. Genetic testing for PRSS1 gene mutations can be beneficial for individuals with a family history of pancreatitis or those who have had multiple episodes of unexplained pancreatitis. Identifying a mutation in the PRSS1 gene can help with early diagnosis, appropriate management, and genetic counseling for affected individuals and their family members. It is important to note that a positive genetic test for PRSS1 gene mutations does not necessarily mean an individual will develop pancreatitis. Other genetic and environmental factors also play a role in the development of the condition. Therefore, the results of genetic testing should be interpreted in the context of a person’s clinical history and other risk factors. |